Turning data into action, insights into impact
Our industry experts empower biopharma leaders to solve brand, portfolio, and organizational challenges – helping teams to move faster and deliver greater impact.
We go beyond advice to help you define what’s next. By translating complex science and business insights into high-impact strategies, we accelerate access, improve outcomes, and deliver measurable value across the product lifecycle.
Asset and development strategy, feasibility, and integrated evidence generation and planning.
Product, portfolio, and launch planning, market entry, research, benchmarking, forecasting and valuation, gross-to-net forecasting, and post-launch optimization.
Healthcare professional (HCP), patient, payer, and provider insights, mapping, engagement, and activation.
Congress coverage, landscape and pipeline analysis, commercial organization benchmarking, competitive simulations, launch analogs, and generics and biosimilars assessments.
Situational analysis, strategy, corrective action plan administration, submission documentation, and negotiation.
Governance and compliance, business process support and optimization, system reference guidance, integrated business process and systems training, and transition readiness and change enablement.
Explore our latest thinking and how we partner with clients to tackle complex challenges and advance the future of healthcare.
Connected medical affairs. Driving impact and outcomes
We partner with medical affairs teams to address their most complex and pressing challenges – from ensuring your narrative cuts through in complex therapeutic areas, to connecting your scientific publications with real-world clinical impact.
Your clinical data must flow seamlessly through your organization to your external audiences, to drive improvements in clinical practice. We optimize every stage of your data journey by applying our unique approaches to strategic storytelling, smart content development, workflow redesign, and AI enablement.
By redefining how medical affairs and medical communications work together, we help change clinical practice, enable meaningful patient engagement, and improve outcomes over the long term.
Our ambition is to build connected, agile, value-driven medical functions – translating complex data into compelling scientific narratives that educate, engage, and inspire the audiences that matter most.
Scientific platform development, integrated evidence generation and synthesis, medical affairs strategy, and impact assessments.
End-to-end services and enhancement tactics through consulting, technology, and managed service solutions.
Strategic stakeholder mapping and engagement, advisory boards, scientific meetings, HCP communities and digital portals, medical science liaison (MSL) and field force training and engagement, and therapeutic awareness campaigns.
Patient insights and mapping, experience assessments, plain language summaries, patient authorship, and empowerment programs.
Explore our latest thinking and how we partner with clients to tackle complex challenges and advance the future of healthcare.
From launch to lasting impact
Two Labs, an Envision Pharma Group company, specializes in helping emerging and mid-sized biopharma companies bring therapies to market with speed, precision, and confidence.
We understand the unique challenges smaller manufacturers face, including limited resources, compressed timelines, and complex regulatory landscapes. That’s why Two Labs offers tailored commercialization support that’s agile, scalable, and grounded in real-world experience.
Whether you’re preparing for your first launch or expanding your portfolio, Two Labs helps you navigate the path from approval to adoption, ensuring your therapy reaches the right patients, faster.
Specialty launch, contracting, licensing, third-party logistics, specialty distribution, and post-launch optimization.
Trade management, Drug Supply Chain Security Act (DSCSA) and serialization, vendor mapping, selection, contracting, and implementation.
Direct-to-consumer hubs, call centers, patient services, and training.
State licensing, drug pricing transparency, compendia listing and management, electronic health record administration and adherence, pharma license administration and adherence, and Sunshine Act transparency.
Explore our latest thinking and how we partner with clients to tackle complex challenges and advance the future of healthcare.
Compliance, clarity, and control
Our comprehensive capabilities support manufacturers in navigating the complexities of market access strategy development, US government program compliance, and commercial contracting with channel partners to drive sustainable access and financial outcomes.
By combining deep industry expertise with advanced, purpose‑built technology, Riparian streamlines critical processes, enhances visibility and accuracy, and strengthens regulatory and operational discipline.
We empower life sciences manufacturers to optimize performance, reduce risk, and drive transformative outcomes with greater transparency, efficiency, and long‑term sustainability.
The Riparian Cloud Platform (RCP), ranked Top 10 Enterprise Solution Provider by PharmaTech Outlook magazine, comprises a full end-to-end revenue management solution for master data management, chargeback processing, gross-to-net forecasting, rebate adjudication, and government pricing.
Enable manufacturers at all stages of maturity to optimize their resources and lower operating expense by leveraging industry experts to identify, implement, and execute best practices for critical business operations (GP, government and commercial rebate adjudication, master data management).
Market-leading advisory services supporting clients with complex US regulations and commercial contracting to optimize strategy and financial outcomes through advanced analytics, implementation of new regulations, operational and systems enhancement, and staff augmentation.
End-to-end market access capabilities that enable manufacturers to optimize strategy and gross-to-net across the product lifecycle, including early-phase value assessment, demonstrating value through HEOR, payer landscape analysis, price setting, launch planning and execution, in-line and LOE evaluation, and payer engagement.
Explore our latest thinking and how we partner with clients to tackle complex challenges and advance the future of healthcare.
Transforming possibilities into progress
At Envision, innovation is at the heart of everything we do. We invest in proprietary technology platforms and AI-driven solutions that help our clients move faster, make smarter decisions, and achieve measurable results.
All our in-house platforms are purpose-built for the life sciences industry, enabling seamless collaboration, data integration, and optimized workflows across medical communications, commercialization, and revenue management.
We harness AI to translate complex data into actionable insights, predict future outcomes, and support strategic decision-making. Our AI capabilities are woven into our services and platforms, driving efficiency, accuracy, and innovation for our clients.
We collaborate with leading technology providers and industry leaders to deliver cutting-edge solutions. By combining our expertise with theirs, we ensure our clients benefit from the latest advancements and a truly integrated approach.
Explore our latest thinking and how we partner with clients to tackle complex challenges and advance the future of healthcare.
